Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Meiosis 1 arrest protein (M1AP) is a testis-expressed protein essential for the progression of meiosis and formation of crossovers during spermatogenesis in males[1][2][4][5]. Mutations in the M1AP gene are associated with autosomal recessive male infertility, including non-obstructive azoospermia and severe oligozoospermia, due to arrest of meiosis at metaphase I[1][2][5]. M1AP is involved in stabilizing recombination intermediates during male meiosis by acting as a sex-specific copartner of the ZZS complex (including SHOC1, TEX11, and SPO16) and facilitating recruitment of TEX11 to recombination sites[1]. It forms foci along chromosome axes in spermatocytes and is essential for proper homologous chromosome crossover and segregation[1][2]. Both knockout models in mice and human genetic studies confirm M1AP's critical, sex-specific function in male fertility, while its role in female meiosis appears dispensable[1][2][3][4][5]. M1AP is not a classic druggable therapeutic target (such as a receptor or enzyme), but it is a pathogenic gene relevant for genetic diagnosis and counseling in cases of male infertility[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Meiosis 1 arrest protein (M1AP).